Abstract
The R141H mutation in the PMM2 gene is the most frequent mutation in type Ia of the congenital disorders of glycosylation (formerly carbohydrate-deficient glycoprotein syndromes)(CDG-Ia). However, it has never been observed in the homozygous state. Homozygosity for this mutation is probably incompatible with life. In this study, we determined the frequency of R141H in two normal populations: in neonates of Dutch origin 1/79 were carriers, whilst in the Danish population, a carrier frequency of 1/60 was found. These figures are clearly in disequilibrium with the frequency of CDG-Ia that has been estimated at 1/80 000 to 1/40 000 in these populations. Haplotype analysis of 43 patients with the R141H mutation of different geographic origins indicated that the R141H is an old mutation in the Caucasian population. Based on the new data, the disease frequency has been calculated at 1/20 000 in these populations. It is concluded that the disease is probably underdiagnosed.
Similar content being viewed by others
Article PDF
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Schollen, E., Kjaergaard, S., Legius, E. et al. Lack of Hardy-Weinberg equilibrium for the most prevalent PMM2 mutation in CDG-Ia (congenital disorders of glycosylation type Ia). Eur J Hum Genet 8, 367–371 (2000). https://doi.org/10.1038/sj.ejhg.5200470
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.ejhg.5200470
Keywords
This article is cited by
-
A PMM2-CDG caused by an A108V mutation associated with a heterozygous 70 kilobases deletion case report
Italian Journal of Pediatrics (2022)
-
Epidemiology of congenital disorders of glycosylation (CDG)—overview and perspectives
Journal of Rare Diseases (2022)
-
GMPPB-congenital disorders of glycosylation associate with decreased enzymatic activity of GMPPB
Molecular Biomedicine (2021)
-
Antenatal manifestations of inborn errors of metabolism: biological diagnosis
Journal of Inherited Metabolic Disease (2016)
-
Clinical utility gene card for: Phosphomannomutase 2 deficiency
European Journal of Human Genetics (2014)